Optimal vaccination strategies for 2009 pandemic H1N1 and seasonal influenza vaccines in humans.
A randomized clinical trial was conducted to assess whether the immunogenicity of seasonal and pandemic (H1N1/09) influenza vaccines is affected by the order of vaccine administration. 151 healthy adult volunteers were randomized into three groups. All groups received one dose (15 μg haemagglutinin)...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2011
|
| _version_ | 1797061357667876864 |
|---|---|
| author | Wu, J Zhong, X Li, C Zhou, J Lu, M Huang, K Dong, M Liu, Y Luo, F Du, N Chui, C Liu, L Smith, N Li, B Shi, N Song, L Gao, Y Wang, D Wang, X Zhu, W Yan, Y Li, Z Chen, J Mcmichael, A Yin, W |
| author_facet | Wu, J Zhong, X Li, C Zhou, J Lu, M Huang, K Dong, M Liu, Y Luo, F Du, N Chui, C Liu, L Smith, N Li, B Shi, N Song, L Gao, Y Wang, D Wang, X Zhu, W Yan, Y Li, Z Chen, J Mcmichael, A Yin, W |
| author_sort | Wu, J |
| collection | OXFORD |
| description | A randomized clinical trial was conducted to assess whether the immunogenicity of seasonal and pandemic (H1N1/09) influenza vaccines is affected by the order of vaccine administration. 151 healthy adult volunteers were randomized into three groups. All groups received one dose (15 μg haemagglutinin) each of a pandemic H1N1 vaccine and a seasonal trivalent vaccine. Group 1 received the pandemic H1N1 vaccine first, followed by the seasonal vaccine 21 days later. Group 2 received vaccinations in vice versa and Group 3 received both vaccines simultaneously. Post-vaccination blood samples were collected to determine the immunogenicity by hemagglutination-inhibition (HI), microneutralization (MN), and B cell ELISPOT assays. All three vaccination strategies were well-tolerated and generated specific immune responses. However, we found a significant difference in magnitude of antibody responses to pandemic H1N1 between the three groups. Pre- or co-vaccination with the seasonal flu vaccine led to a significant reduction by 50% in HI titre to pandemic H1N1 virus after pandemic vaccination. Pre- or co-vaccination of pandemic H1N1 vaccine had no effect on seasonal flu vaccination. MN and ELISPOT assays showed a similar effect. Vaccination with pandemic H1N1 vaccine first is recommended to avoid an associated inhibitory effect by the seasonal trivalent flu vaccine. |
| first_indexed | 2024-03-06T20:29:57Z |
| format | Journal article |
| id | oxford-uuid:30b51797-063e-4adc-a7ed-2421d62ee396 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T20:29:57Z |
| publishDate | 2011 |
| record_format | dspace |
| spelling | oxford-uuid:30b51797-063e-4adc-a7ed-2421d62ee3962022-03-26T13:03:18ZOptimal vaccination strategies for 2009 pandemic H1N1 and seasonal influenza vaccines in humans.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:30b51797-063e-4adc-a7ed-2421d62ee396EnglishSymplectic Elements at Oxford2011Wu, JZhong, XLi, CZhou, JLu, MHuang, KDong, MLiu, YLuo, FDu, NChui, CLiu, LSmith, NLi, BShi, NSong, LGao, YWang, DWang, XZhu, WYan, YLi, ZChen, JMcmichael, AYin, WA randomized clinical trial was conducted to assess whether the immunogenicity of seasonal and pandemic (H1N1/09) influenza vaccines is affected by the order of vaccine administration. 151 healthy adult volunteers were randomized into three groups. All groups received one dose (15 μg haemagglutinin) each of a pandemic H1N1 vaccine and a seasonal trivalent vaccine. Group 1 received the pandemic H1N1 vaccine first, followed by the seasonal vaccine 21 days later. Group 2 received vaccinations in vice versa and Group 3 received both vaccines simultaneously. Post-vaccination blood samples were collected to determine the immunogenicity by hemagglutination-inhibition (HI), microneutralization (MN), and B cell ELISPOT assays. All three vaccination strategies were well-tolerated and generated specific immune responses. However, we found a significant difference in magnitude of antibody responses to pandemic H1N1 between the three groups. Pre- or co-vaccination with the seasonal flu vaccine led to a significant reduction by 50% in HI titre to pandemic H1N1 virus after pandemic vaccination. Pre- or co-vaccination of pandemic H1N1 vaccine had no effect on seasonal flu vaccination. MN and ELISPOT assays showed a similar effect. Vaccination with pandemic H1N1 vaccine first is recommended to avoid an associated inhibitory effect by the seasonal trivalent flu vaccine. |
| spellingShingle | Wu, J Zhong, X Li, C Zhou, J Lu, M Huang, K Dong, M Liu, Y Luo, F Du, N Chui, C Liu, L Smith, N Li, B Shi, N Song, L Gao, Y Wang, D Wang, X Zhu, W Yan, Y Li, Z Chen, J Mcmichael, A Yin, W Optimal vaccination strategies for 2009 pandemic H1N1 and seasonal influenza vaccines in humans. |
| title | Optimal vaccination strategies for 2009 pandemic H1N1 and seasonal influenza vaccines in humans. |
| title_full | Optimal vaccination strategies for 2009 pandemic H1N1 and seasonal influenza vaccines in humans. |
| title_fullStr | Optimal vaccination strategies for 2009 pandemic H1N1 and seasonal influenza vaccines in humans. |
| title_full_unstemmed | Optimal vaccination strategies for 2009 pandemic H1N1 and seasonal influenza vaccines in humans. |
| title_short | Optimal vaccination strategies for 2009 pandemic H1N1 and seasonal influenza vaccines in humans. |
| title_sort | optimal vaccination strategies for 2009 pandemic h1n1 and seasonal influenza vaccines in humans |
| work_keys_str_mv | AT wuj optimalvaccinationstrategiesfor2009pandemich1n1andseasonalinfluenzavaccinesinhumans AT zhongx optimalvaccinationstrategiesfor2009pandemich1n1andseasonalinfluenzavaccinesinhumans AT lic optimalvaccinationstrategiesfor2009pandemich1n1andseasonalinfluenzavaccinesinhumans AT zhouj optimalvaccinationstrategiesfor2009pandemich1n1andseasonalinfluenzavaccinesinhumans AT lum optimalvaccinationstrategiesfor2009pandemich1n1andseasonalinfluenzavaccinesinhumans AT huangk optimalvaccinationstrategiesfor2009pandemich1n1andseasonalinfluenzavaccinesinhumans AT dongm optimalvaccinationstrategiesfor2009pandemich1n1andseasonalinfluenzavaccinesinhumans AT liuy optimalvaccinationstrategiesfor2009pandemich1n1andseasonalinfluenzavaccinesinhumans AT luof optimalvaccinationstrategiesfor2009pandemich1n1andseasonalinfluenzavaccinesinhumans AT dun optimalvaccinationstrategiesfor2009pandemich1n1andseasonalinfluenzavaccinesinhumans AT chuic optimalvaccinationstrategiesfor2009pandemich1n1andseasonalinfluenzavaccinesinhumans AT liul optimalvaccinationstrategiesfor2009pandemich1n1andseasonalinfluenzavaccinesinhumans AT smithn optimalvaccinationstrategiesfor2009pandemich1n1andseasonalinfluenzavaccinesinhumans AT lib optimalvaccinationstrategiesfor2009pandemich1n1andseasonalinfluenzavaccinesinhumans AT shin optimalvaccinationstrategiesfor2009pandemich1n1andseasonalinfluenzavaccinesinhumans AT songl optimalvaccinationstrategiesfor2009pandemich1n1andseasonalinfluenzavaccinesinhumans AT gaoy optimalvaccinationstrategiesfor2009pandemich1n1andseasonalinfluenzavaccinesinhumans AT wangd optimalvaccinationstrategiesfor2009pandemich1n1andseasonalinfluenzavaccinesinhumans AT wangx optimalvaccinationstrategiesfor2009pandemich1n1andseasonalinfluenzavaccinesinhumans AT zhuw optimalvaccinationstrategiesfor2009pandemich1n1andseasonalinfluenzavaccinesinhumans AT yany optimalvaccinationstrategiesfor2009pandemich1n1andseasonalinfluenzavaccinesinhumans AT liz optimalvaccinationstrategiesfor2009pandemich1n1andseasonalinfluenzavaccinesinhumans AT chenj optimalvaccinationstrategiesfor2009pandemich1n1andseasonalinfluenzavaccinesinhumans AT mcmichaela optimalvaccinationstrategiesfor2009pandemich1n1andseasonalinfluenzavaccinesinhumans AT yinw optimalvaccinationstrategiesfor2009pandemich1n1andseasonalinfluenzavaccinesinhumans |